N-(4-bromo-2-methylphenyl)pivalamide

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: N-(4-bromo-2-methylphenyl)pivalamide
• 英文别名: N-(4-bromo-2-methylphenyl)-2,2-dimethylpropanamide
• 化学式: C₁₂H₁₆BrNO
• mdl: MFCD03576196
• 分子量: 270.169
• InChiKey: SVIPZLVKLGRAQC-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.4
• 重原子数：
  15
• 可旋转键数：
  2
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.416
• 拓扑面积：
  29.1
• 氢给体数：
  1
• 氢受体数：
  1

反应信息

• 作为产物：
  描述：

  2,4-二溴苯胺 在 正丁基锂 、 甲基锂 、 三乙胺 作用下， 以 乙醚 为溶剂， 反应 18.0h， 生成 N-(4-bromo-2-methylphenyl)pivalamide
  参考文献：
  名称：

  Stanetty, Peter; Krumpak, Barbara; Rodler, Inge K., Journal of Chemical Research, Miniprint, 1995, # 9, p. 2111 - 2122

  摘要：

  DOI：

文献信息

• Solvent-free aromatic C–H functionalisation/halogenation reactions
  作者：Robin B. Bedford、Jens U. Engelhart、Mairi F. Haddow、Charlotte J. Mitchell、Ruth L. Webster

  DOI：10.1039/c0dt00385a

  日期：——

  The solvent-free, palladium-catalysed reaction of anilides with CuCl2 in the presence or absence of copper acetate yields ortho-chlorinated anilides in good to excellent yields, even on a large scale (100 mmol). By contrast, the equivalent reactions with copper bromide, either solvent free or in 1,2-dichloroethane, in the presence or absence of palladium, under air or inert conditions, gave the products

  无溶剂 钯催化的苯甲酸酯与 氯化铜2 在存在或不存在的情况下 醋酸铜即使大规模（100 mmol），也能以良好或优异的收率得到邻氯代苯甲酸酯。相比之下，与溴化铜，无溶剂或在 1,2-二氯乙烷，无论是否存在 钯在空气或惰性条件下，得到简单的亲电子溴化产物。机理研究突显了Palladacyclic中间体的参与，其中之一在结晶学上已得到表征，随后会与之发生反应。铜（II），氯化 产生氯化苯胺产品。
• Site-Selective C–H Functionalization of (Hetero)Arenes via Transient, Non-symmetric Iodanes
  作者：Stacy C. Fosu、Chido M. Hambira、Andrew D. Chen、James R. Fuchs、David A. Nagib

  DOI：10.1016/j.chempr.2018.11.007

  日期：2019.2

  A strategy for C–H functionalization of arenes and heteroarenes has been developed to allow site-selective incorporation of various anions, including Cl, Br, OMs, OTs, and OTf. This approach is enabled by in situ generation of reactive, non-symmetric iodanes by combining anions and bench-stable PhI(OAc)2. The utility of this mechanism is demonstrated via para-selective chlorination of medicinally relevant

  已经开发了一种将芳烃和杂芳烃进行C-H官能化的策略，以允许位点选择性结合各种阴离子，包括Cl，Br，OMs，OTs和OTf。通过结合阴离子和稳定的PhI（OAc）2原位生成反应性，不对称碘化物，可以实现此方法。该机制的实用性通过与药用相关的芳烃的对位选择性氯化以及杂芳烃的位点选择性C–H氯化反应得以证明。光谱，计算和竞争实验描述了这些瞬态，不对称碘的独特性质，反应性和选择性。
• Cooperativity within the catalyst: alkoxyamide as a catalyst for bromocyclization and bromination of (hetero)aromatics
  作者：Haripriyo Mondal、Md Raja Sk、Modhu Sudan Maji

  DOI：10.1039/d0cc04673f

  日期：——

  Alkoxyamide has been reported as a catalyst for the activation of N-bromosuccinimide to perform bromocyclization and bromination of a wide range of substrates in a lipophilic solvent, where adequate suppression of the background reactions was observed. The key feature of the active site is the alkoxy group attached to the sulfonamide moiety, which facilitates the acceptance as well as the delivery

  据报道，烷氧基酰胺是一种催化剂，用于在亲脂性溶剂中活化N-溴琥珀酰亚胺来进行溴化和各种底物的溴化反应，并观察到对本底反应的充分抑制。活性位点的关键特征是连接至磺酰胺部分的烷氧基，这有助于将溴物种从溴源接收到基质以及从基质向基质的传递。
• GYRASE INHIBITORS AND USES THEREOF
  申请人：Charifson PAUL

  公开号：US20090325955A1

  公开（公告）日：2009-12-31

  The present invention relates to methods of treating, preventing, or lessening the severity of resistant bacterial infections in mammals, utilizing compounds of formula I or formula VII or pharmaceutically salts thereof. The present invention also relates to methods of using compounds of formula I or formula VII in combination with one or more additional antibacterial agents and/or one or more additional therapeutic agents that increase the susceptibility of bacterial organisms to antibiotics.

  本发明涉及使用化合物I或化合物VII或其药学盐在哺乳动物中治疗、预防或减轻耐药细菌感染的方法。本发明还涉及使用化合物I或化合物VII与一个或多个额外的抗菌剂和/或一个或多个增加细菌对抗生素敏感性的治疗剂相结合的方法。
• Gyrase Inhibitors and Uses Thereof
  申请人：Charifson Paul

  公开号：US20120010222A1

  公开（公告）日：2012-01-12

  The present invention relates to methods of treating, preventing, or lessening the severity of resistant bacterial infections in mammals, utilizing compounds of formula I or formula VII or pharmaceutically salts thereof. The present invention also relates to methods of using compounds of formula I or formula VII in combination with one or more additional antibacterial agents and/or one or more additional therapeutic agents that increase the susceptibility of bacterial organisms to antibiotics.

  本发明涉及使用I式或VII式化合物或其药学盐治疗、预防或减轻哺乳动物中耐药细菌感染的方法。本发明还涉及使用I式或VII式化合物与一种或多种额外的抗菌剂和/或一种或多种增加细菌对抗生素易感性的治疗剂联合使用的方法。